A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea
Completed · Not applicable
Conditions studied: Pain Catastrophizing, Primary Dysmenorrhea
In brief
The purpose of this study is to test the feasibility and efficacy of a brief group therapy treatment program focused on reducing pain catastrophizing in adolescents and young adults (ages 16-25) with menstrual pain.
Key facts
- Study ID
- NCT02640079
- Run by
- University of California, Los Angeles
- People needed
- 24
- Starts
- 2016-01-01
- Expected to finish
- 2017-11-01
- Last updated by the study team
- 2018-04-13
Who can join
Age: 16 and older, up to 25. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female ages 16-25 years
- Self-reported menstrual cycle averaging 24-32 days
- Menstrual pain rating of ≥4 on the Numeric Rating Scale for at least the previous three menstrual cycles prior to participation
- Written informed consent or assent (if a minor, parent must also provide written parental permission)
- Able to read and understand English
You may not qualify if…
- Use of oral contraceptives or any exogenous hormones in the previous 3 months
- Presence of persistent pelvic pain throughout the menstrual cycle
- Acute illness or injury that may impact lab performance or that affects sensitivity of the extremities
- Diagnosis of an underlying medical cause for dysmenorrhea symptoms
- No or minimal menstrual pain (NRS rating of ≤ 3) during any of the 3 previous cycles prior to study participation
- Daily use of opioids; participants using other analgesics will be included, but will be asked not to take these analgesics on the days of the lab sessions
- Developmental delay, autism, or significant anatomic impairment that may preclude understanding of study procedures
Where it is running
- University of California, Los Angeles — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.